Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
Furthering the boundaries of BTK treatment with Shockwave E8
Join Dr. Thulasidasan, Interventional Cardiologist at St. Thomas's Hospital in London, as he discusses the challenges of the below-the-knee peripheral artery disease and reviews a Shockwave E8 case in a 70-year-old patient with type 2 diabetes. Dr. Thulasidasan is a paid consultant of Shockwave Medical. Views expressed are those of the authors and not necessarily those of Shockwave Medical.
Shockwave Important Safety Information: https://shockwavemedical.com/important-safety-information-universal/
